StockData
GH Research PLC logo

GH Research PLC (GHRS) stock

GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$18.27−0.48 (-2.56%)

Close on Nov 17, 2026Market cap $1.13BP/E –Yield –

GH Research cash

Cash and short-term investments held at the end of each period.

GH Research's cash was $345.05M at Jun 30, 2026. For fiscal 2025 it was $246.25M, up 144.3% from the year before. The highest annual figure on record is $276.78M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$246.25M+144.3%
FY2024Dec 31, 2024$100.79M+28.5%
FY2023Dec 31, 2023$78.42M-52.7%
FY2022Dec 31, 2022$165.96M-40.0%
FY2021Dec 31, 2021$276.78M+4595.1%
FY2020Dec 31, 2020$5.90M+1083.7%
FY2019Dec 31, 2019$498.00K–
FY2018Dec 31, 2018$0–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$345.05M+35.9%
Q1 FY2026Mar 31, 2026$242.65M-0.9%
Q4 FY2025Dec 31, 2025$246.25M+144.3%
Q3 FY2025Sep 30, 2025$249.65M+177.2%
Q2 FY2025Jun 30, 2025$253.87M+191.4%
Q1 FY2025Mar 31, 2025$244.95M+216.1%
Q4 FY2024Dec 31, 2024$100.79M+28.5%
Q3 FY2024Sep 30, 2024$90.06M+4.2%
Q2 FY2024Jun 30, 2024$87.13M-10.1%
Q1 FY2024Mar 31, 2024$77.48M-26.3%
Q4 FY2023Dec 31, 2023$78.42M-52.7%
Q3 FY2023Sep 30, 2023$86.44M-66.4%
Q2 FY2023Jun 30, 2023$96.90M-63.5%
Q1 FY2023Mar 31, 2023$105.08M-62.0%
Q4 FY2022Dec 31, 2022$165.96M+2715.2%
Q3 FY2022Sep 30, 2022$256.94M+51494.2%
Q2 FY2022Jun 30, 2022$265.38M–
Q4 FY2021Dec 31, 2021$276.78M–
Q4 FY2020Dec 31, 2020$5.90M–
Q4 FY2019Dec 31, 2019$498.00K–
Q4 FY2018Dec 31, 2018$0–

More GH Research figures

See a number that looks wrong?